LuminaX HealthTech Accelerator Program (LX)

Purpose and Program Overview

The LuminaX HealthTech Accelerator Program Queensland is an Australian accelerator. It supports early-stage HealthTech startups. The program operates from the Gold Coast Health and Knowledge Precinct at Cohort Innovation Space. Its goal is to speed up the commercialisation and growth of innovative health technology solutions. It provides selected startups with investment, expert guidance, access to clinical trials, research networks, and industry partnerships. This helps quickly move products from prototype to market readiness.

Since its start in 2021, LuminaX has supported over 40 HealthTech startups. It has driven significant growth and funding outcomes in biotechnology, medical devices, AI-powered health solutions, and digital health sectors. The 2025 group continues this work with diverse startups. They work closely with over 40 mentors, industry leaders, clinicians, and investors. LuminaX enhances Queensland’s standing as a centre for health innovation. It also helps with national health system transformation and economic development.

The program works with key institutions. These include Griffith University, Gold Coast Hospital and Health Service, Economic Development Queensland, and the Queensland Investment Corporation. This creates an environment that supports startup scaling. It does this through funding, knowledge sharing, and clinical validation. The program is one of only a few accelerators in Australia to gain ESIC (Early Stage Innovation Company) eligibility, offering tax incentives for investors.

Key Grant Details

• Grant amount: Up to AUD 200,000 investment per startup. Also, AUD 50,000 in-kind program support. LuminaX takes no equity (2024–25 terms).
• Application open: Applications for 2026 open in January 2026. For 2025, applications opened in January and closed in March.
• Program duration: 12 to 14 weeks. This is an immersive, in-person accelerator program.
• Eligible industries/business types: Australian HealthTech startups. Focus areas include biotechnology, medical devices, AI health solutions, digital health, and related fields.
• Co-contributions: No mandatory co-contribution. Investment includes capital plus in-kind support.
• Location/state/territory applicability: Based in Queensland, primarily the Gold Coast region. Open to Australian startups. Relevance to Queensland’s health innovation ecosystem is essential. A $2,000 travel allowance is available for interstate companies.

Priority Sectors

The accelerator targets explicitly the HealthTech sector. This includes:

• Biotechnology.
• Medical devices and diagnostics.
• Artificial intelligence and machine learning applications in health.
• Digital health and telemedicine.
• Clinical innovations and therapeutics.

This focus matches current industry trends and the strategic priorities of Queensland’s health and knowledge precinct. The aim is to grow a globally competitive life sciences group.

Funding Scope

• Investment amount per startup: Up to AUD 200,000 cash investment.
• In-kind support: Valued at AUD 50,000 per startup. This includes mentorship, coaching, access to clinical trials, workspace, and network connections.
• Program timeline: Intensive 12–14 week cohort-based accelerator. It includes workshops, mentoring sessions, and pitch opportunities.
• Additional funding: Access to a network of venture capital funds and early-stage investors is provided throughout the program. LuminaX has helped startups raise over $24 million in direct funding through its VC partners and mentors since 2021.

Grant Amount in Total

The total funding pool is not publicly stated. LuminaX has invested approximately AUD 5.3 million in startups since its inception. This is supported by multiple funding partners.

Eligibility Criteria

• Early-stage Australian HealthTech startups. They should have an operational presence or willingness to operate within Queensland.
• Developing innovative products or services in biotechnology, medical devices, AI health, digital health, or related sectors.
• Demonstrated product or technology with potential for clinical validation or commercial scale-up.
• Registered Australian business with a valid ABN and relevant business registrations.
• Capacity to commit to a 12–14 week immersive accelerator program in Gold Coast, Queensland.
• Must have passed the ideation phase and developed an MVP or early product.

Eligible Activities and Expenses

• Development and refinement of health technology products.
• Participation in clinical trials and validation studies.
• Business development, market access strategies, and regulatory pathway planning.
• Mentorship, coaching, and networking with health industry experts and investors.
• Engagement in investor pitch events and capital raising activities.
• Use of a dedicated workspace during the program.

Assessment Process of LuminaX HealthTech Accelerator Program

This is a competitive application process. Selection is based on:

• Project merit and innovation in the health sector.
• Team capability and commitment to the program.
• Strategic alignment with Queensland’s health innovation priorities.
• Commercial potential and readiness for market scale-up.

Selected startups undergo a rigorous 12–14 week accelerator. This includes ongoing evaluation and direct investor engagement. The program has ESIC eligibility, which can provide significant tax incentives for investors.

Recent Program Updates

The 2025 LuminaX cohort launched in April. It includes 11 startups and 22 founders. These are supported by 40 mentors. Partnerships are strengthened with Griffith University, Gold Coast Hospital and Health Service, and Queensland Investment Corporation. This increases capital flow to participants. The focus on AI, biotech, and digital health innovations continues. This aligns with recent national health technology investment trends. Applications for the 2025 program opened in Q1 2024 and closed in March. Future rounds are expected annually.

Application Tips

• Carefully review the specific requirements around HealthTech focus and Queensland-based participation.
• Prepare a strong business case. Demonstrate product innovation, market validation, and readiness for clinical trials or commercialisation.
• Understand the program’s intensive format and resource commitments.
• Highlight team expertise, commercial vision, and capacity for rapid growth.
• Gather relevant documentation. This includes business registration, product data, and financials as per application guidelines.
• Attend any information sessions or online events offered by LuminaX.

Where to Get Help

Consider consulting with a professional grant specialist like Pattens Group. We offer initial assessments to review your business’s eligibility and evaluate how well your project aligns with the grant’s objectives. You can also visit the LuminaX HealthTech Accelerator Program website or Queensland Government innovation portals for official application materials and further guidance.